Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Jaguar Animal Health, Inc. (JAGX : NSDQ)
 
 • Company Description   
Jaguar Health, Inc. is a natural-products pharmaceuticals company. It focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals. The company through its subsidiary Napo Pharmaceuticals Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals. Its product pipeline consists of Mytesi(R), Canalevia(TM), Equilevia(TM) and Neonorm (TM). Jaguar Health Inc., formerly known as Jaguar Animal Health Inc., is based in San Francisco, United States.

Number of Employees: 34

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.68 Daily Weekly Monthly
20 Day Moving Average: 15,205,824 shares
Shares Outstanding: 139.44 (millions)
Market Capitalization: $234.26 (millions)
Beta: 1.49
52 Week High: $4.47
52 Week Low: $0.19
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -1.18% -2.24%
12 Week -6.67% -12.58%
Year To Date 106.14% 82.53%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
200 PINE STREET SUITE 400
-
SAN FRANCISCO,CA 94104
USA
ph: 415-371-8300
fax: -
None http://www.jaguaranimalhealth.com
 
 • General Corporate Information   
Officers
Lisa A. Conte - Chief Executive Officer and President
Lisa A. Conte - Chief Executive Officer; President and Director
Karen S. Wright - Chief Financial Officer
Jiahao Qiu - Director
Zhi Yang, Ph.D. - Director

Peer Information
Jaguar Animal Health, Inc. (GSAC)
Jaguar Animal Health, Inc. (CASI)
Jaguar Animal Health, Inc. (ALCD.)
Jaguar Animal Health, Inc. (OMNN)
Jaguar Animal Health, Inc. (CGPI.)
Jaguar Animal Health, Inc. (ISR)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: 47010C409
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/21
Next Expected EPS Date: 08/12/21
Share - Related Items
Shares Outstanding: 139.44
Most Recent Split Date: 6.00 (0.01:1)
Beta: 1.49
Market Capitalization: $234.26 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.18 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/12/21  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 6.85
Price/Cash Flow: -
Price / Sales: 24.01
EPS Growth
vs. Year Ago Period: 82.14%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: 42.81%
vs. Previous Quarter: -51.82%
ROE
03/31/21 - -263.79
12/31/20 - -485.93
09/30/20 - -660.01
ROA
03/31/21 - -73.77
12/31/20 - -80.34
09/30/20 - -76.11
Current Ratio
03/31/21 - 3.50
12/31/20 - 1.35
09/30/20 - 0.42
Quick Ratio
03/31/21 - 3.28
12/31/20 - 1.14
09/30/20 - 0.33
Operating Margin
03/31/21 - -350.37
12/31/20 - -320.86
09/30/20 - -328.36
Net Margin
03/31/21 - -388.26
12/31/20 - -360.24
09/30/20 - -372.81
Pre-Tax Margin
03/31/21 - -388.26
12/31/20 - -360.24
09/30/20 - -372.81
Book Value
03/31/21 - 0.25
12/31/20 - 0.15
09/30/20 - 0.03
Inventory Turnover
03/31/21 - 1.25
12/31/20 - 1.30
09/30/20 - 1.38
Debt-to-Equity
03/31/21 - 0.76
12/31/20 - 0.72
09/30/20 - 1.26
Debt-to-Capital
03/31/21 - 43.17
12/31/20 - 41.93
09/30/20 - 25.42
 

Powered by Zacks Investment Research ©